Versant Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Versant Capital Management's RGEN Position: Q3 2026 in Review
Versant Capital Management increased its Repligen (RGEN) stake by 167% in Q3 2026, buying an estimated $1.63K and bringing the position to 16 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2544.
Versant Capital Management first reported a position in RGEN in Q1 2021 and has held it in 18 quarters since. The position peaked at $10K in Q4 2025. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Versant Capital Management held 16 shares of Repligen worth $3.08K as of Q3 2026.
- Versant Capital Management bought 10 Repligen shares in Q3 2026, an estimated $1.63K.
- Repligen made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2544 holding.
- Versant Capital Management first reported a position in Repligen in Q1 2021 and has held it in 18 quarters since.
- Versant Capital Management's Repligen position peaked at $10K in Q4 2025.
- 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.